38 results
8-K
EX-99.1
990ze04 cacnb2enbpt4
25 Mar 24
Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights
4:05pm
8-K
EX-99.1
459y8we4
8 Mar 24
Departure of Directors or Certain Officers
4:01pm
8-K
EX-1.1
23r0y of9g
5 Oct 23
Entry into a Material Definitive Agreement
5:28pm
8-K
EX-99.1
0baygh5e322djcbu 8w
9 Aug 23
Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates
4:06pm
PRE 14A
sq725sgw4e6hmasj vui
31 Mar 23
Preliminary proxy
4:02pm
424B3
f2feym9hpieyppb4u8
10 Nov 22
Prospectus supplement
4:13pm
S-4/A
0o9klmf3o 5o
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
4b9p565setosfo4odk1
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm
425
6gvjbdj
6 Sep 22
Business combination disclosure
4:33pm
8-K
EX-2.1
veg hizroa3tzogs4a
6 Sep 22
Equillium to Acquire Metacrine in All-Stock Transaction
4:29pm
8-K
EX-2.1
g2ov jcyqoijn
16 Feb 22
Equillium Acquires Bioniz Therapeutics
7:01am